243 related articles for article (PubMed ID: 6296743)
1. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
Wiebe RH; Morris CV
Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
[TBL] [Abstract][Full Text] [Related]
2. Androgen and estrogen formation in women with ovarian hyperthecosis.
Aiman J; Edman CD; Worley RJ; Vellios F; MacDonald PC
Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322
[TBL] [Abstract][Full Text] [Related]
3. [Endocrine profile and electron microscopic study of ovarian androblastoma].
Inoue S; Fukuda O; Koyama N; Furuki Y; Munemura M; Maeyama M; Mizumoto J; Miyayama Y
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1155-62. PubMed ID: 6096462
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors.
Meldrum DR; Abraham GE
Obstet Gynecol; 1979 Jan; 53(1):36-43. PubMed ID: 215947
[TBL] [Abstract][Full Text] [Related]
5. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
Dunne C; Havelock JC
J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
[TBL] [Abstract][Full Text] [Related]
6. Arrhenoblastomas and associated ovarian pathology.
Cruikshank DP; Chapler FK
Obstet Gynecol; 1974 Apr; 43(4):539-43. PubMed ID: 4361442
[No Abstract] [Full Text] [Related]
7. Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study.
Roth LM; Cleary RE; Rosenfield RL
Lab Invest; 1974 Dec; 31(6):648-57. PubMed ID: 4280005
[No Abstract] [Full Text] [Related]
8. The levels of androgen in serum in female acne patients.
Schmidt JB; Spona J
Endocrinol Exp; 1985 Mar; 19(1):17-23. PubMed ID: 3157562
[TBL] [Abstract][Full Text] [Related]
9. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.
Pascale MM; Pugeat M; Roberts M; Rousset H; Déchaud H; Dutrieux-Berger N; Tourniaire J
Clin Endocrinol (Oxf); 1994 Nov; 41(5):571-6. PubMed ID: 7828344
[TBL] [Abstract][Full Text] [Related]
10. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
11. [Two case of androgen-secreting ovary tumor].
Dai W; Shi Y; He F; Gu C; Kong Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Aug; 17(4):317-20. PubMed ID: 8575058
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
Haning RV; Loughlin J; Shapiro SS
Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
[TBL] [Abstract][Full Text] [Related]
13. Plasma androgen concentrations and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Hankinson SE
Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
[TBL] [Abstract][Full Text] [Related]
14. Ovarian and adrenal vein steroids in seven patients with androgen-secreting ovarian neoplasms: selective catheterization findings.
Moltz L; Pickartz H; Sörensen R; Schwartz U; Hammerstein J
Fertil Steril; 1984 Oct; 42(4):585-93. PubMed ID: 6237938
[TBL] [Abstract][Full Text] [Related]
15. Hirsutism, polycystic ovarian disease, and ovarian 17-ketosteroid reductase deficiency.
Pang SY; Softness B; Sweeney WJ; New MI
N Engl J Med; 1987 May; 316(21):1295-301. PubMed ID: 3472077
[TBL] [Abstract][Full Text] [Related]
16. The utility of adrenal and ovarian venous sampling in the investigation of androgen-secreting tumours.
Petersons CJ; Burt MG
Intern Med J; 2011 Jan; 41(1a):69-70. PubMed ID: 21265966
[No Abstract] [Full Text] [Related]
17. [Hyperthecosis ovarii--a tumor-like change in androgenized females].
Schwartz U; Moltz L; Pickartz H; Sörensen R; Römmler A
Geburtshilfe Frauenheilkd; 1986 Jun; 46(6):391-7. PubMed ID: 3091442
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
19. A steroid-cell tumor of the ovary resulting in massive androgen excess early in the gonadol steroidogenic pathway.
Stephens JW; Fielding A; Verdaguer R; Freites O
Gynecol Endocrinol; 2008 Mar; 24(3):151-3. PubMed ID: 18335330
[TBL] [Abstract][Full Text] [Related]
20. Selective ovarian vein sampling can be crucial to localize a Leydig cell tumor: an unusual case in a postmenopausal woman.
Ozgun MT; Batukan C; Turkyilmaz C; Dolanbay M; Mavili E
Maturitas; 2008 Nov; 61(3):278-80. PubMed ID: 18930614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
